News
Lonza Group AG / Key word(s): ExpansionLonza Completes Expansion of Conjugation Facility in Visp (CH) 16.02.2023 / 14:00 CET/CEST Expansion adds development and manufacturing capacity for pre-clinical ...
Lonza Group AG / Key word(s): ExpansionLonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites 12.11.2024 / 07:00 CET/CEST The expansion of bioconjugation capabilities ...
LGO Medical also owes MB Financial Bank about $3.1 million. It had accounts payable of about $26,000 and intercompany payables of about $450,000.
At least 30 people could get jobs with LGO Hospitality. The company asks workers to apply in person at the restaurant and be prepared to complete an application and a manager or chef will speak ...
Separately, Lonza plans to spend $212 million on a small-molecule manufacturing complex at the Visp site. The 2,000 m 2 facility will support a long-term contract with an unnamed drug-industry ...
The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related infrastructure to the existing bioconjugation facility in Visp for launch and commercial supply.
All are located at 5695 W. Franklin Drive and are owned by LGO Group, a holding company focused on investing in and operating manufacturing businesses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results